Merck

Science and technology in healthcare, life science, performance materials..

Launch date

1668

Employees

Market cap

Enterprise valuation

$313.4b (Public information from Sep 2024)

Darmstadt Hesse (HQ)

https://www.merckgroup.com/en

https://twitter.com/merckgroup https://www.facebook.com/emdgroup https://www.linkedin.com/company/1485

Corporate Venture Fund: M Ventures

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	48.0b	48.7b	59.3b	60.1b	64.2b	68.5b	72.7b
% growth	2 %	1 %	22 %	1 %	7 %	7 %	6 %
EBITDA	20.6b	20.9b	26.4b	10.1b	28.1b	32.6b	34.9b
% EBITDA margin	43 %	43 %	45 %	17 %	44 %	48 %	48 %
Profit	7.1b	13.0b	14.5b	365m	19.0b	22.9b	25.7b
% profit margin	15 %	27 %	24 %	1 %	30 %	33 %	35 %
EV / revenue	4.8x	4.5x	5.0x	5.1x	5.0x	4.5x	4.0x
EV / EBITDA	11.2x	10.4x	11.3x	30.2x	11.4x	9.4x	8.4x

Date	Investors	Amount	Round
Jan 2002	N/A	N/A	IPO
Total Funding		-

By Country

United States 6 Switzerland 3 France 1 Germany 1

By Industry

Health 10 Semiconductors 1

By Round

ACQUISITION 6 POST IPO EQUITY 1 SERIES H 1 CORPORATE SPINOUT 1 SPINOUT 1 SERIES B 1

Idenix Pharmaceuticals

ACQUISITION by Merck Jun 2014

Moderna Therapeutics

exited

Threshold Pharmaceuticals

ACQUISITION by Molecular Templates Aug 2017

Cubist Pharmaceuticals

ACQUISITION by Merck Dec 2014

ACQUISITION by Merck Jul 2024

Chord Therapeutics

ACQUISITION by Merck Dec 2021

ACQUISITION by Merck Jan 2022

ACQUISITION by Merck Jan 2021